| 1 |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要 [J]. 中国循环杂志, 2021, 36(6): 521-545.
|
| 2 |
黄刚, 邓晓奇, 张小刚, 等. 2020德国永久性心脏辅助装置植入者紧急医疗处置共识 [J]. 心血管病学进展, 2020, 41(12): 1353-1358.
|
| 3 |
Flaherty MP, Khan AR, O'neill WW. Early initiation of impella in acute myocardial infarction complicated by cardiogenic shock improves survival: a meta-analysis [J]. JACC Cardiovasc Interv, 2017, 10(17): 1805-1806.
|
| 4 |
Saku K, Kakino T, Arimura T, et al. Left ventricular mechanical unloading by total support of impella in myocardial infarction reduces in farct size, preserves left ventricular function, and prevents subsequent heart failure in dogs [J]. Circ Heart Fail, 2018, 11(5): e004397.
|
| 5 |
Esposito ML, Zhang Y, Qiao X, et al. Left ventricular unloading before reperfusion promotes functional recovery after acute myocardial infarction [J]. J Am Coll Cardiol, 2018, 72(5): 501-514.
|
| 6 |
Vargas KG, JaGer B, Kaufmann CC, et al. Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis [J]. Wien Klin Wochenschr, 2020, 132(23-24): 716-725.
|
| 7 |
Flaherty MP, Pant S, Patel SV, et al. Hemodynamic support with a microaxial percutaneous left ventricular assist device (Impella) protects against acute kidney injury in patients undergoing high-risk percutaneous coronary intervention [J]. Circ Res, 2017, 120(4): 692-700.
|
| 8 |
中华医学会心血管病学分会;中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019) [J]. 中华心血管病杂志, 2019, (10): 766-783.
|
| 9 |
Spillmann F, Van Linthout S, Schmidt G, et al. Mode-of-action of the PROPELLA concept in fulminant myocarditis [J]. Eur Heart J, 2019, 40(26): 2164-2169.
|
| 10 |
Tschope C, Van Linthout S, Klein O, et al. Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts [J]. J Cardiovasc Transl Res, 2019, 12(2): 116-123.
|
| 11 |
Bettari L, Pero G, Maiandi C, et al. Exploring personal protection during high-risk PCI in a COVID-19 patient: impella CP mechanical support during ULMCA bifurcation stenting [J]. JACC Case Rep, 2020, 2(9): 1279-1283.
|
| 12 |
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association [J]. Circulation, 2017, 135(10): e146-e603.
|
| 13 |
Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials [J]. J Am Coll Cardiol, 2016, 67(14): 1674-1683.
|
| 14 |
Goldstein JA, Kern MJ. Percutaneous mechanical support for the failing right heart [J]. Cardiol Clin, 2012, 30(2): 303-310.
|
| 15 |
Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device [J]. J Heart Lung Transplant, 2015, 34(12): 1549-1560.
|
| 16 |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018 [J]. 中华心力衰竭和心肌病杂志, 2018, 46(10): 760-789.
|
| 17 |
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC [J]. Eur Heart J, 2016, 37(27): 2129-2200.
|
| 18 |
Pleger ST, Brinks H, Ritterhoff J, et al. Heart failure gene therapy: the path to clinical practice [J]. Circ Res, 2013, 113(6): 792-809.
|
| 19 |
Tharakan S, Kariya T, Yamada K, et al. Improving gene therapy efficacy using impella [J]. J Heart Lung Transplant, 2020, 39(4): S357-S358.
|
| 20 |
Khaliel F, Moss E, Demers P, et al. A bailout approach: Transaxillary Impella implantation in toxic cardiomyopathy [J]. Asian Cardiovasc Thorac Ann, 2014, 22(6): 722-724.
|
| 21 |
Elkayam U, Schäfer A, Chieffo A, et al. Use of Impella heart pump for management of women with peripartum cardiogenic shock [J]. Clin Cardiol, 2019, 42(10): 974-981.
|
| 22 |
Ishikawa K, Watanabe S, Lee P, et al. Acute left ventricular unloading reduces atrial stretch and inhibits atrial arrhythmias [J]. J Am Coll Cardiol, 2018, 72(7): 738-750.
|
| 23 |
Mariani S, Richter J, Pappalardo F, et al. Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis [J]. Int J Cardiol, 2020, 316: 31-39.
|
| 24 |
Diaz Quintero L, Gajo E, Guerrero M, et al. Balloon aortic valvuloplasty followed by Impella(R)-assisted left main coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve replacement [J]. Cardiovasc Revasc Med, 2021, 22: 16-21.
|
| 25 |
Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance [J]. Asaio J, 2005, 51(3): 296-300.
|
| 26 |
Wohns D, Muthusamy P, Davis AT, et al. Economic and operational implications of a standardized approach to hemodynamic support therapy using percutaneous cardiac assist devices [J]. Innovations (Phila), 2014, 9(1): 38-42.
|
| 27 |
Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support [J]. Circulation, 2020, 141(4): 273-284.
|
| 28 |
O'neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT Ⅱ study [J]. Circulation, 2012, 126(14): 1717-1727.
|
| 29 |
Briasoulis A, Telila T, Palla M, et al. Meta-analysis of usefulness of percutaneous left ventricular assist devices for high-risk percutaneou s coronary interventions [J]. Am J Cardiol, 2016, 118(3): 369-375.
|
| 30 |
Travis AR, Giridharan GA, Pantalos GM, et al. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device [J]. J Thorac Cardiovasc Surg, 2007, 133(2): 517-524.
|
| 31 |
Southmayd G, Hoque A, Kaki A, et al. Percutaneous large-bore axillary access is a safe alternative to surgical approach: A systematic review [J]. Catheter Cardiovasc Interv, 2020, 96(7): 1481-1488.
|
| 32 |
Crowley J, Cronin B, Essandoh M, et al. Transesophageal Echocardiography for Impella Placement and Management[J]. J Cardiothorac Vasc Anesth, 2019, 33(10): 2663-2668.
|
| 33 |
Den Uil CA, Jewbali LS, Heeren MJ, et al. Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation [J]. Eur J Heart Fail, 2017, 19 Suppl 2: 104-109.
|
| 34 |
Schrage B, Becher P M, Bernhardt A, et al. Left ventricular unloading is associated with lower mortality in cardiogenic shock patients treated with veno-arterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study [J]. Circulation, 2020, 142(22): 2095-2106.
|
| 35 |
申华, 杜俣, 马晓腾, 等. PIE-2R模式救治急性心肌梗死合并心源性休克患者的初步临床经验 [J]. 中华医学杂志, 2019, 99(28): 2208-2213.
|
| 36 |
Tschope C, Alogna A, Faragli A, et al. Case report first-in-man method description: left ventricular unloading with iVAC2L during veno-arterial extracorporeal membrane oxygenation: from veno-arterial extracorporeal membrane oxygenation to ECMELLA to EC-iVAC(R) [J]. Front Cardiovasc Med, 2020, 7: 563448.
|